Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a new trial coordinator. The “first-in-class” platform will address the top ...
Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...
Deloitte’s patient engagement platform suite ConvergeHealth on Feb. 18 launched a new digital platform on Amazon Web Services that connects patients and investigators with clinical research trials.
ALS — also often called Lou Gehrig’s disease — is a progressive, neurodegenerative disease with no cure. Despite its devastating impact, the pace of new therapy development has remained sluggish — ...
MELBOURNE, Australia, Dec. 11, 2025 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results